The DOI matches its Crossref record; 287 of the 287 references it cites were found in a registry or an index.
Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
Open accessAbstract
SUMMARY: The only natural reservoir of Neisseria meningitidis is the human nasopharyngeal mucosa. Depending on age, climate, country, socioeconomic status, and other factors, approximately 10% of the human population harbors meningococci in the nose. However, invasive disease is relatively rare, as it occurs only when the following conditions are fulfilled: (i) contact with a virulent strain, (ii) colonization by that strain, (iii) penetration of the bacterium through the mucosa, and (iv) survival and eventually outgrowth of the meningococcus in the bloodstream. When the meningococcus has reached the bloodstream and specific antibodies are absent, as is the case for young children or after introduction of a new strain in a population, the ultimate outgrowth depends on the efficacy of the innate immune response. Massive outgrowth leads within 12 h to fulminant meningococcal sepsis (FMS), characterized by high intravascular concentrations of endotoxin that set free high concentrations of proinflammatory mediators. These mediators belonging to the complement system, the contact system, the fibrinolytic system, and the cytokine system induce shock and diffuse intravascular coagulation. FMS can be fatal within 24 h, often before signs of meningitis have developed. In spite of the increasing possibilities for treatment in intensive care units, the mortality rate of FMS is still 30%. When the outgrowth of meningococci in the bloodstream is impeded, seeding of bacteria in the subarachnoidal compartment may lead to overt meningitis within 24 to 36 h. With appropriate antibiotics and good clinical surveillance, the mortality rate of this form of invasive disease is 1 to 2%. The overall mortality rate of meningococcal disease can only be reduced when patients without meningitis, i.e., those who may develop FMS, are recognized early. This means that the fundamental nature of the disease as a meningococcus septicemia deserves more attention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–287 of 287
Riordan, F. A. I., Thomson, A. P. J., Sills, J. A., & Hart, C. A. (1996) · BMJ · doi:10.1136/bmj.313.7067.1255 · Cited by 67
Meningococcal Disease in Los Angeles County, California, and among Men in the County Jails
Tappero, J. W., Reporter, R., Wenger, J. D., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609193351201 · Cited by 67
Zangwill, K. M. (1997) · JAMA · doi:10.1001/jama.1997.03540290041030 · Cited by 66
Meningococcal meningitis with ‘normal’ cerebrospinal fluid
Coll, M.-T., Uriz, M.-S., Pineda, V., Fontanals, D., Bella, F., Nava, J. M., Deulofeu, F., Morera, M.-A., Martí, C., Lite, J., et al. (1994) · Journal of Infection · doi:10.1016/s0163-4453(94)91197-5 · Cited by 65
Westendorp, R. G. J., Langermans, J. A. M., de Bel, C. E., et al. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.4.1057 · Cited by 64
Brandtzaeg, P., Hagasen, K., Kierulf, P., & Mollnes, T. E. (1996) · The Journal of Infectious Diseases · doi:10.1093/infdis/173.3.647 · Cited by 62
Self-citationSerogroup B, Electrophoretic Type 15Neisseria meningitidisin Canada
Kertesz, D. A., Coulthart, M. B., Ryan, J. A., et al. (1998) · The Journal of Infectious Diseases · doi:10.1086/517439 · Cited by 61
Friedland, I. R., Jafari, H. S., Ehrett, S., et al. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/168.3.657 · Cited by 60
Case Fatality of Meningococcal Disease in Western Norway
Halstensen, A. I., Pedersen, S. H. J., Haneberg, B., Bjorvatn, B., & SOLBERG, C. O. (1987) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365548709032375 · Cited by 60
Prognostic factors in acute meningococcaemia.
Lewis, L. S. (1979) · Archives of Disease in Childhood · doi:10.1136/adc.54.1.44 · Cited by 60
Granier, S., Owen, P., Pill, R., & Jacobson, L. (1998) · BMJ · doi:10.1136/bmj.316.7127.276 · Cited by 59
van Furth, A. M., Seijmonsbergen, E. M., Langermans, J. A. M., Groeneveld, P. H. P., de Bel, C. E., & van Furth, R. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/21.1.220 · Cited by 59
Current status of meningococcal group B vaccine candidates: capsular or noncapsular?
Romero, J. D., & Outschoorn, I. (1994) · Clinical Microbiology Reviews · doi:10.1128/cmr.7.4.559-575.1994 · Cited by 57
Neisseria meningitidis strains with decreased susceptibility to penicillin
Esso, D. V., Fontanals, D., Úriz, S., MORERA, M. A., Juncosa, T., Latorre, C., & DURAN, M. (1987) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198705000-00003 · Cited by 57
Stephens, D. S., Whitney, A. M., Rothbard, J. B., & Schoolnik, G. K. (1985) · The Journal of Experimental Medicine · doi:10.1084/jem.161.6.1539 · Cited by 57
Ayala, P., Lin, L., Hopper, S., Fukuda, M., & So, M. (1998) · Infection and Immunity · doi:10.1128/iai.66.10.5001-5007.1998 · Cited by 57
Myocardial dysfunction in children with acute meningococcemia
Boucek, M. M., Boerth, R. C., Artman, M., Graham, T. P., & Boucek, R. J. (1984) · The Journal of Pediatrics · doi:10.1016/s0022-3476(84)80416-3 · Cited by 55
Ceesay, S. J., Allen, S. J., Menon, A., Todd, J., Cham, K., Carlone, G. M., Turner, S. H., Gheesling, L. L., DeWitt, W. E., Plikaytis, B. D., et al. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1212 · Cited by 55
Barquet, N. (1997) · JAMA · doi:10.1001/jama.278.6.491 · Cited by 54
Hart, C. A., & Rogers, T. R. (1993) · Journal of Medical Microbiology · doi:10.1099/00222615-39-1-3 · Cited by 54
Haneberg, B., Tønjum, T., Rodahl, K., et al. (1983) · PubMed · Cited by 54
Vogel, U. F., Claus, H., Heinze, G., & Frosch, M. (1999) · Infection and Immunity · doi:10.1128/iai.67.2.954-957.1999 · Cited by 53
Waage, A., & Aasen, A. O. (1992) · Immunological Reviews · doi:10.1111/j.1600-065x.1992.tb01416.x · Cited by 52
PLASMAPHERESIS FOR FULMINANT MENINGOCOCCEMIA
Drapkin, M. S., Wisch, J. S., Gelfand, J. A., Cannon, J. G., & Dinarello, C. A. (1989) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-198906000-00015 · Cited by 51
(1976) · JAMA · doi:10.1001/jama.1976.03260290019018 · Cited by 50
Sprung, C. L., Caralis, P., Marcial, E. H., Pierce, M., CELBARD, M. A., LONG, W. N., DUNCAN, R. C., Tendler, M. D., & Karpf, M. (1985) · Survey of Anesthesiology · doi:10.1097/00132586-198508000-00028 · Cited by 49
Raza, M. W., Ahmer, O. R. E., OGILVIE, M. M., Blackwell, C. C., Saadi, A. T., Elton, R. A., & Weir, D. M. (1999) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1999.tb01230.x · Cited by 48
Vitovski, S., Read, R. C., & Sayers, J. R. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.2.331 · Cited by 48
Plasma exchange does not improve survival in a canine model of human septic shock
Natanson, C., Hoffman, W. D., Koev, L. A., Dolan, D. P., Banks, S. M., Bacher, J., Danner, R. L., Klein, H. G., & Parrillo, J. E. (1993) · Transfusion · doi:10.1046/j.1537-2995.1993.33393174451.x · Cited by 47
Relation between cytokines and routine laboratory data in children with septic shock and purpura
Hazelzet, J. A., van der Voort, E., Lindemans, J. W., ter Heerdt, P. G. J., & Neijens, H. J. (1994) · Intensive Care Medicine · doi:10.1007/bf01720912 · Cited by 46
Scholten, R. J. P. M., POOLMAN, J. T., Valkenburg, H. A., Bijlmer, H. A., Dankert, J., & Caugant, D. A. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.3.673 · Cited by 44
Extremity Amputations in Meningococcemia-Induced Purpura Fulminans
Genoff, M. C., Hoffer, M. M., Achauer, B. M., & Formosa, P. (1992) · Plastic & Reconstructive Surgery · doi:10.1097/00006534-199205000-00015 · Cited by 44
MENINGOCOCCAL COLONIZATION AND INFECTION IN CHILDREN AND THEIR HOUSEHOLD CONTACTS
Marks, M. I., Frasch, C. E., & Shapera, R. M. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112714 · Cited by 44
Brandtzaeg, P., Sirnes, K. E., Folsland, B., Godal, H. C., Kierulf, P., Bruun, J., & Dobloug, J. H. (1985) · PubMed · Cited by 43
Self-citationAbramson, J. S., & Spika, J. S. (1985) · The Journal of Infectious Diseases · doi:10.1093/infdis/151.2.370 · Cited by 43
Reducing mortality from meningococcal disease.
Begg, N. T. (1992) · BMJ · doi:10.1136/bmj.305.6846.133 · Cited by 41
Brandtzaeg, P., Halstensen, A. I., Kierulf, P., Espevik, T., & Waage, A. (1992) · Microbial Pathogenesis · doi:10.1016/0882-4010(92)90010-l · Cited by 41
Self-citationCirculating Leukemia Inhibitory Factor Levels Correlate With Disease Severity In Meningococcemia
Waring, P. M., Waring, L., & Metcalf, D. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/170.5.1224 · Cited by 41
Stuart, J. M., Cartwright, K. A. V., Robinson, P. M., & Noah, N. D. (1989) · BMJ · doi:10.1136/bmj.298.6673.569 · Cited by 40
Tumour necrosis factor alpha antibody protects against lethal meningococcaemia
Nassif, X., Mathison, J. C., Wolfson, E. B., Koziol, J. A., Ulevitch, R. J., & Son, M. (1992) · Molecular Microbiology · doi:10.1111/j.1365-2958.1992.tb01505.x · Cited by 39
Rayner, C. F., Dewar, A. L., Moxon, E. R., Virji, M., & Wilson, R. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.1.113 · Cited by 38
Priority during a meningitis epidemic: Vaccination or treatment
Veeken, H., Ritmeijer, K., & Hausman, B. (1998) · The Indian Journal of Pediatrics · doi:10.1007/bf02831349 · Cited by 37
Chemoprophylaxis for Bacterial Infections: Principles of and Application to Meningococcal Infections
Schwartz, B. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.supplement_2.s170 · Cited by 37
Efficacy of Ciprofloxacin in the Treatment of Nasopharyngeal Carriers of Neisseria meningitidis
Pugsley, M. P., Dworzack, D. L., Horowitz, E. A., Cuevas, T. A., Sanders, W. E., & Sanders, C. C. (1987) · The Journal of Infectious Diseases · doi:10.1093/infdis/156.1.211 · Cited by 37
Adrenal, cutaneous and myocardial lesions in fulminating endotoxinemia
Böhm, N. (1982) · Pathology - Research and Practice · doi:10.1016/s0344-0338(82)80032-0 · Cited by 36
Caugant, D. A., Høiby, E. A., Frøholm, L. O., & Brandtzæ, P. (1996) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549609049066 · Cited by 36
Molecular Epidemiology of Sporadic (Endemic) Serogroup C Meningococcal Disease
Raymond, N. J., Reeves, M. W., Ajello, G. W., Baughman, W., Gheesling, L. L., Carlone, G. M., Wenger, J. D., & Stephens, D. S. (1997) · The Journal of Infectious Diseases · doi:10.1086/514123 · Cited by 36
Tw, G.-D., Høiby, E. A., Schillinger, A., LYSTAD, A., & Bøvre, K. (1983) · PubMed · Cited by 36
Zhu, P., Hu, X., & Xu, L. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.2.458-462.1995 · Cited by 35
van Deuren, M., Frieling, J. T. M., van der Ven‐Jongekrijg, J., Neeleman, C., Rüssel, F. G. M., van Lier, H. J. J., & van der Meer, J. W. M. (1998) · Clinical Infectious Diseases · doi:10.1086/513933 · Cited by 34
False positive diagnosis of meningococcal infection by the IS1106 PCR ELISA
Borrow, R., Guiver, M., Sadler, F., Kaczmarski, E. B., & Fox, A. J. (1998) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.1998.tb13001.x · Cited by 32
Rapid detection of meningococci from petechiae in acute meningococcal infection
Periappuram, M., Taylor, M. R. H., & Keane, C. (1995) · Journal of Infection · doi:10.1016/s0163-4453(95)80027-1 · Cited by 31
Differential alterations in plasma colony-stimulating factor concentrations in meningococcaemia
Waring, P. M., Presneill, J., Maher, D. W., Layton, J. E., Cebon, J. S., Waring, L., & Metcalf, D. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03844.x · Cited by 31
The early management of meningococcal disease.
Hodgetts, T., Brett, A. S., & Castle, N. R. (1998) · Emergency Medicine Journal · doi:10.1136/emj.15.2.72 · Cited by 30
Acute Meningococcaemia: Recent Advances in Management (with Particular Reference to Children)
Kennedy, N. J., & Duncan, A. W. (1996) · Anaesthesia and Intensive Care · doi:10.1177/0310057x9602400212 · Cited by 29
Response of Neisseria meningitidis to iron limitation
Pettersson, A. M., POOLMAN, J. T., van der Ley, P., & Tommassen, J. (1997) · Antonie van Leeuwenhoek · doi:10.1023/a:1000179301748 · Cited by 27
Versuche zur Serodiagnostik und Serotherapie der epidemischen Genickstarre1)
Jochmann, G. (1906) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0028-1142033 · Cited by 27
Prognostic indicators of the outcome of meningococcal disease: a study of 562 patients
Lodder, M. C., Schildkamp, R. L., Bijlmer, H. A., Dankert, J., Kuik, D. J., & Scholten, R. J. P. M. (1996) · Journal of Medical Microbiology · doi:10.1099/00222615-45-1-16 · Cited by 26
Meningococcal disease in Wales: Clinical features, outcome and public health management
Palmer, S. R., Corson, J., Hall, R., et al. (1992) · Journal of Infection · doi:10.1016/0163-4453(92)91699-c · Cited by 25
Microbial utilization of human signalling molecules
Virji, M. (1996) · Microbiology · doi:10.1099/13500872-142-12-3319 · Cited by 25
Sonoclot coagulation analysis and plasma exchange in a case of meningococcal septicaemia
Schött, U., & Björsell-Östling, E. (1995) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/bf03010573 · Cited by 24
Meningococcal and ECHO‐9 meningitis: Report of an outbreak
Levitt, L. P., Bond, J. O., Hall, I. E., Dame, G. M., BUFF, E. E., Marston, C., & Prather, E. (1970) · Neurology · doi:10.1212/wnl.20.1.45 · Cited by 23
Does splenectomy predispose to meningococcal sepsis? An experimental study and clinical review
Loggie, B. W., & Hinchey, E. J. (1986) · Journal of Pediatric Surgery · doi:10.1016/s0022-3468(86)80195-6 · Cited by 22
Optimising the investigation of meningococcal disease
Cartwright, K. A. V., & Kroll, S. (1997) · BMJ · doi:10.1136/bmj.315.7111.757 · Cited by 22
Reversible Adrenocorticol Insufficiency in Fulminant Meningococcemia
Bosworth, D. C. (1979) · Archives of Internal Medicine · doi:10.1001/archinte.139.7.823 · Cited by 22
No increase in endotoxin release during antibiotic killing of meningococci
Prins, J. M. (1997) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/39.1.13 · Cited by 22
Hypoglycemia, hormones and cytokines in fatal meningococcal septicemia
Romijn, J. A., Godfried, M. H., Wortel, C. H., & Sauerwein, H. P. (1990) · Journal of Endocrinological Investigation · doi:10.1007/bf03349613 · Cited by 21
Brandtzaeg, P., Js, D., & Høiby, E. A. (1983) · PubMed · Cited by 21
Self-citationHaneberg, B., Gutteberg, T. J., Pj, M., Østerud, B., Bjorvatn, B., & Eh, L. (1983) · PubMed · Cited by 21
Plasma exchange and haemodiafiltration in fulminant meningococcal sepsis.
Kumar, A., Kanagasundaram, N. S., Collyns, T. A., & Davison, A. M. (1998) · Nephrology Dialysis Transplantation · doi:10.1093/oxfordjournals.ndt.a027853 · Cited by 20
Newcombe, J., Dyer, S., Blackman, L., Cartwright, K. A. V., Palmer, W. H., McFadden, J., & Blackwell, L. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.7.1809-1812.1997 · Cited by 20
van Deuren, M., van der Meer, J. W. M., Neeleman, C., & Hek, L. G. V. (1998) · Intensive Care Medicine · doi:10.1007/s001340050538 · Cited by 20
Recognizing meningococcal disease: the case for further research in primary care.
Granier, S., Owen, P., & Stott, N. C. H. (1998) · Europe PMC (PubMed Central) · Cited by 19
van Deuren, M., Netea, M. G., Hijmans, A., Demacker, P. N. M., Neeleman, C., Sauerwein, R. W., Bartelink, A. K. M., & van der Meer, J. W. M. (1998) · The Journal of Infectious Diseases · doi:10.1086/517824 · Cited by 18
Jarisch-Herxheimer Reaction in Meningococcal Meningitis
Berkowitz, F. E. (1983) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.1983.02140320075018 · Cited by 17
Reasons for delay in administration of antibiotics to patients with meningitis and meningococcaemia
Wilks, D., & Lever, A. M. L. (1996) · Journal of Infection · doi:10.1016/s0163-4453(96)80009-0 · Cited by 17
Disseminated Intravascular Coagulation, Antithrombin III, and Complement in Meningococcal Infections
Laursen, B., Faber, V., Brock, A., Gormsen, J., & Sørensen, H. (1981) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1981.tb11581.x · Cited by 16
Pharyngeal carriage of Neisseria meningitidis before and after treatment of meningococcal disease
Weis, N. M., & Lind, I. (1994) · Journal of Medical Microbiology · doi:10.1099/00222615-41-5-339 · Cited by 16
Schlichting, E., Lyberg, T., Solberg, O., & Andersen, B. M. (1993) · Scandinavian Journal of Infectious Diseases · doi:10.3109/00365549309008547 · Cited by 15
The early phase of meningococcal disease.
Tønjum, T., Nilsson, F., Jn, B., & Haneberg, B. (1983) · PubMed · Cited by 15
Some arguments on early hospital admission and treatment of suspected meningococcal disease cases.
Tw, G.-D., Høiby, E. A., Brandtzaeg, P., Eskerud, J., & Bøvre, K. (1990) · PubMed · Cited by 13
Self-citationHow long is too long? Determining the early management ofmeningococcal disease in Birmingham
Wood, A. L., & O’Brien, S. J. (1996) · Public Health · doi:10.1016/s0033-3506(96)80109-0 · Cited by 12
Early management of meningococcal disease.
Cm, W., Jessop, E. G., & Mc, W. (1995) · PubMed · Cited by 12
Severe human septic shock involves more than tumor necrosis factor.
Brandtzaeg, P., Waage, A., Mollnes, T. E., Øktedalen, O., & Kierulf, P. (1991) · PubMed · Cited by 11
Self-citationDuffy, T. P. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309023291007 · Cited by 10
Meningococcal Meningitis with a Benign Skin Rash
Rubenstein, R., & Esteriy, N. B. (1986) · Pediatric Dermatology · doi:10.1111/j.1525-1470.1986.tb00553.x · Cited by 9
Schubiger, G., Munzinger, J., Dudli, C., & Wipfli, U. (1986) · PubMed · Cited by 9
Cited by
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Raetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404
Epidemic meningitis, meningococcaemia, and Neisseria meningitidis
Stephens, D. S., Greenwood, B., & Brandtzaeg, P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61016-2 · Cited by 978
Self-citationIntracellular Targeting Mechanisms by Antimicrobial Peptides
Le, C.-F., Fang, C.-M., & Sekaran, S. D. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02340-16 · Cited by 603
Clinical recognition of meningococcal disease in children and adolescents
Thompson, M. J., Ninis, N., Perera, R., Mayon-White, R., Phillips, C., Bailey, L., Harnden, A., Mant, D., & Levin, M. (2006) · The Lancet · doi:10.1016/s0140-6736(06)67932-4 · Cited by 565
Metadata
- Authors
- van Deuren, M., Brandtzaeg, P., & van der Meer, J. W. M.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2000-01
- Volume
- 13
- Issue
- 1
- Pages
- 144-166
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2096532993
- Cited by
- 588
- References
- 287
- FWCI
- 25.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.